Thromboelastography and its use in cardiac surgery;Tromboelastografi ve kalp cerrahisinde kullanimi

Anadolu Kardiyoloji Dergisi

Volumn 8, Issue 2, 2008, Pages 154-162

  Ak, Koray ^a   Atalan, Nazan ^a   Tekeli, Atike ^a   Işbir, Selim ^a   Civelek, Ali ^a   Nesrin, Emekli ^b   Arsan, Sinan ^a  

^a MARMARA UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

Author keywords

Haemostatic system and cardiac surgery; Thromboelastography

Indexed keywords

ABCIXIMAB; ACETYLSALICYLIC ACID; AMINOCAPROIC ACID; APROTININ; ASPIRN; CLOPIDOGREL; CYANOCOBALAMIN; HEPARIN; HIRULOG; LEPIRUDIN; PROTAMINE; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT HIRUDIN; TRANEXAMIC ACID;

BLOOD CLOTTING DISORDER; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; FIBRINOLYSIS; HEART SURGERY; HEMOSTASIS; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; MICROANGIOPATHY; PARTIAL THROMBOPLASTIN TIME; PERIOPERATIVE PERIOD; PROTHROMBIN TIME; REVIEW; THROMBOCYTE DYSFUNCTION; THROMBOELASTOGRAPHY;

CARDIOVASCULAR DISEASES; CORONARY ARTERY BYPASS; HUMANS; THROMBELASTOGRAPHY;

EID: 42549104142     PISSN: 13028723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Hartert H. Blutgerinnungsstudien mit der Thrombelastographie, einem nounen Untersuchungsverfahren. Klin Wochenschr 1948; 26: 577-83.
2. Despotis GJ, Avidan MS, Hogue CW. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 2001; 72: 1821-31.
3. Shander A, Moskowitz D, Rijhwani TS. The safety and efficacy of "bloodless" cardiac surgery. Semin Cardiothorac Vasc Anesth 2005; 9: 53-63.
4. Luddington RJ. Thromboelastography/thromboelastometry. Clin Lab Haematol 2005; 27: 131-90.
5. Traverso CI, Caprini JA, Arcelus JI. The normal thromboelastogram and its interpretation. Seminars in Thrombosis and Hemostasis 1995; 21: 7-13(suppl).
6. Manspeizer HE, Imai M, Frumento RJ, Parides MK, Mats B, Bennett-Guerrero E. Arterial and venous thrombelastography variables differ during cardiac surgery. Anesth Analg. 2001; 93: 277-81.
7. Miller BE, Guzzetta NA, Tosone SR, Miller JL, Flunker AR, Silvey EM, at al. Tissue factor-activated thromboelastograms in children undergoing cardiac surgery: baseline values and comparisons. Anesth Analg 2003; 97: 1289-93.
8. Garton HJ, Warren ER, Simpson NA, Lyons GR, Columb MO. Thromboelastography identifies sex-related differences in coagulation. Anesth Analg 2000; 91: 1279-131.
9. Lang T, Bauters A, Braun SL, Potzsch B, von Pape KW, Kolde HJ, et al. Multi-centre investigation on reference ranges for ROTEM thromboelastometry. Blood Coagul Fibrinolysis 2005; 16: 301-10.
10. Khuri SF, Wolfe A Josa M, Axford TC, Szymanski I, Assousa S, et al. Hemotologic changes during and after cardiopulmoner bypass and their relationship to the bleeding time and nonsurgical blood loss. J Thorac Cardiovasc Surg 1992; 104: 94-107.
11. Civelek A, Ak K, Akgün S, Işbir S, Yildinm T, Öz M, et al. Aspirin ve Clopidogrel'in Koroner Arter Baypas Greftlemesi sonrasi Kanama Üzerine etkisi. I. Ü Kardiyol Enst Derg 2003; 2: 26-30.
12. Hardy JF, Perrault J, Tremblay N, Robitaille D, Blain R, Carrier M. The stratification of cardiac surgical procedures according to use of blood products: a retrospective analysis of 1480 cases. Can J Anaesth 1991; 38: 511-7.
13. Heimark RL, Kurachi K, Fujikawa K, Davie EW. Surface activation of blood coagulation. Fibrinolysis and kinin formation. Nature 1980; 286: 456-60.
14. Boisclair MD, Lane DA, Philippou H, Esnouf MP, Sheikh S, Hunt B, et al. Mechanism of thrombin generation during surgery and cardiopulmonary bypass. Blood 1993; 82: 3350-7.
15. Khuri SF, Valeri CR, Loscalzo J, Weinstein MJ, Birjiniuk V, Healey NA et al. Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg 1995; 60: 1008-14.
16. Kozek-Langenecker SA, Mohammad SF, Masaki T, Kamerath C, Cheung AK. The effects of heparin, protamine, and heparinase 1 on platelets in vitro using whole blood flow cytometry. Anesth Analg 2000; 90: 8013-12.
17. Despotis GJ, Joist JH, Goodnough LT. Monitoring of hemostasis in cardiac surgical patients: impact of point-of-care testing on blood loss and transfusion outcomes. Clin Chem 1997; 43: 16B4-96.
18. Holloway DS, Summaria L, Sandesara J, Vagher JP, Alexander JC, Caprini J.A. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost 1988; 59: 62-7.
19. Wachtfogel YT, Kucich U, Grenplate J, Gluszko P, Abrams W, Weinbaum G, et al. Human neuraphil degranulation during extracorporeal circulation. Blood 1987; 69: 324-30.
20. Cramer EM, Lu H, Caen JP, Soria C, Berndt MC, Tenza D. Differential redistribution of platelet glycoproteins Ib and Ilb-Illa after plasmin stimulation. Blood 1991; 77: 694-9.
21. Edmunds LH, Jr. and Colman RW. Extracorporeal Circulation: Thrombosis and Bleeding. In: Cohn LH, Edmunds LH, Jr, editors. 2nd ed. Card. Surg. Adult, New York: McGraw-Hill; 2003. p. 338-48.
22. Bailey JM, Tanaka KA, Levy JH. Cardiac surgical pharmacology. In: Cohn LH, Edmunds LH, Jr, editors. Cardiac Surger in Adult 2nd ed. New York: McGraw-Hill; 2003. p. 85-118.
23. Ember JA, Jagels MA, Hugli TE. Characterization of complement anaphylatoxins and their biological responses. In Volankis JE, Frank MM, editors. 3rd Ed. The Human Complement System in Health and Disease. New York: Marcel Dekker; 1998. p. 241.
24. Kappelmayer J, Bernabei A, Gikakis N, Edmunds LH Jr, Colman RW. Upregulation of Mac-1 surface expression on neutrophils during simulated extracorporeal circulation. J Lab Clin Mad 1993; 121: 113.
25. Kappelmayer J, Bernabei A, Edmunds LH Jr, Edgington TS, Colman RW. Tissue factor is expressed on monocytes during simulated extracorporeal circulation. Circ Res 1993; 72: 1075.
26. Zimmermann N, Kienzle P, Weber AA, Winter J, Gams E, Schror K, at al. Aspirin resistance after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2001; 121: 982-4.
27. Dacey LJ, Munoz JJ, Baribeau YR, Johnson ER, Lahey SJ, Leavitt BJ, et al. Reexploration for hemorrhage following coronary artery bypass grafting: Incidence and risk factors. Northern Now England Cardiovascular Disease Study Group. Arch Surg 1998; 133: 442-7.
28. Goodnough LT, Johnston MF, Toy PT. The variability of transfusion practice in coronary artery bypass surgery. Transfusion Medicine Academic Award Group. JAMA 1991; 265: 86-90.
29. Stover EP, Siegel LC, Parks R, Levin J, Body SC, Maddi R, et al. Variability in transfusion practice for coronary artery bypass surgery persists despite national consensus guidelines: a 24-institution study. Institutions of the Multicenter Study of Perioperative Ischemia Research Group. Anesthesiology 1998; 88: 327-33.
30. Alvarez JM, Jackson LR, Chatwin C, Smolich JJ. Low-dose postoperative aprotinin reduces mediastinal drainage and blood product use in patients undergoing primary coronary artery bypass grafting who are taking aspirin: a prospective, randomized, double-blind, placebo-controlled trial. J Thorac Cardiovase Surg 2001; 122: 457-63.
31. Levy JH. Pharmacologic preservation of the hemostatic system during cardiac surgery. Ann Thorac Surg 2001; 72: 1814-20.
32. Avidan MS, Da Fonseca J, Parmar K, Alcock E, Ponte J, Hunt BJ. The effects of aprotinin on thromboelastography with three different activators. Anesthesiology 2001; 95: 1169-74.
33. Ronald A, Dunning J. Can the use of thromboelastography predict and decrease bleeding and blood and blood product requirements in adult patients undergoing cardiac surgery? Interact CardioVasc Thorac Surg 2005; 4: 456-63.
34. Mongan PD, Hosking MP. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology. 1992; 77: 38-46.
35. Poston RS, Gu J, Brown JM, Gammie JS, White C, Nie L, et al. Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting. J Thorac Cardiovasc Surg 2006; 131: 122-30.
36. Işbir S, Ak K, Aksoy N, Tekeli A, Civelek A, Tetik Ş, et al. Asetylsalicylic acid resistance in coronary artery surgery. Heart Surgery Forum 2005; 8 (Suppl 1): 10 (abstract).
37. Yilmaz MB, Balbay Y, Çalchr V, Ayaz S, Güray Y, Gbray U, et al. Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance. Thromb Res 2005; 115: 25-9.
38. Cammerer U, Dietrich W, Rampf T, Braun SL, Richter JA. The predictive value of modified computerized thromboelastography and platelet function analysis for postoperative blood loss in routine cardiac surgery. Anesth Analg. 2003; 96: 51-7.
39. Mittermayr M, Margreiter J, Velik-Salchner C, Klingler A, Streif W, Fries D, et al. Effects of protamine and heparin can be detected and easily differentiated by modified thromboelastography (Rotem): an in vitro study. Br J Anaesth 2005; 95: 310-6.
40. Ereth MH, Nuttall GA, Klindworth A MacVeigh I, Santrach PJ, Orszulak TA, et al. Does the platelet-activated clotting test (HemoSTATUS) predict blood loss and platelet dysfunction associated with cardiopulmonary bypass? Anesth Analg 1997; 85: 259-64.
41. Shore-Lesserson L. Evidence based coagulation monitors: heparin monitoring, thromboelastography, and platelet function. Semin Cardiothorac Vasc Anesth 2005; 9: 41-52.
42. Williams GD, Bratton SL, Nielsen NJ, Ramamoorthy C. Fibrinolysis in pediatric patients undergoing cardiopulmonary bypass. J Cardiothorac Vasc Anesth. 1998; 12: 633-8.
43. Kettner SC, Kozek SA, Groetzner JP, Gonano C, Schellongowski A, Kucera M, et al. Effects of hypothermia on thromboelastography in patents undergoing cardiopulmonary bypass. Br J Anaesth 1998; 80: 313-7.
44. Spiess BD, Gillies BS, Chandler W, Verrier E. Changes in transfusion therapy and reexploration rate after institution of a blood management program in cardiac surgical patients. J Cardiothorac Vasc Anesth 1995; 9: 168-73.
45. Royston D, von Kier S. Reduced haemostatic factor transfusion using heparinase-modified thromboelastography during cardiopulmonary bypass. Br J Anaesth 2001; 86: 575-8.
46. Avidan MS, Alcock EL, Hunt BJ, Ponte J, Desai JB, Despotis GJ, et al. Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 2004; 92: 178-86.
47. Shore-Lesserson L, Manspeizer HE, DePerio M, Francis S, Vela-Cantos F, Ergin MA. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88: 312-9.
48. Nuttall GA, Oliver WC, Ereth MH, Santrach PJ. Coagulation tests predict bleeding after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997; 11: 815-23.
49. Ak K, Aksoy N, Tekeli A, Adademir T, Civelek A, Işbir S, et al. The use of thromboelastography-guided transfusion algorithm in cardiac surgery. Proceedings of the 2nd annual congress of Update on Cardiology and Cardiovascular Surgery: 2006; 20-24 Sept 2006 Bodrum, Turkey. (abstract).
50. Despotis GJ, Goodnough LT. Management approaches to platelet-related microvascular bleeding in cardiothoracic surgery. Ann Thorac Surg 2000; 70: 20-32.